Cardivas 3.125 Tablet

Product Introduction

Cardivas 3.125 Tablet is a prescription medication that contains carvedilol as its active ingredient. Carvedilol is a non-selective beta-blocker with alpha-blocking activity, primarily used in the management of cardiovascular conditions. The tablet is designed to be taken orally, typically prescribed for patients with hypertension (high blood pressure) and heart failure. By combining both beta-adrenergic and alpha-adrenergic blocking properties, Cardivas 3.125 Tablet helps in reducing heart rate, blood pressure, and strain on the heart. This dual action makes it particularly effective in managing conditions that involve high blood pressure and heart function abnormalities.

Uses of Cardivas 3.125 Tablet

Cardivas 3.125 Tablet is primarily used to treat:

• Hypertension (High Blood Pressure): By relaxing blood vessels and slowing heart rate, it helps in lowering blood pressure, thereby reducing the risk of strokes, heart attacks, and kidney problems.
• Heart Failure: Carvedilol improves the heart’s efficiency and reduces symptoms such as shortness of breath, swelling in the legs, and fatigue. It is often used in conjunction with other medications to enhance overall heart function.
• Left Ventricular Dysfunction Following Myocardial Infarction: This condition occurs when the left ventricle of the heart does not pump effectively post-heart attack. Cardivas 3.125 helps in improving survival rates and reduces the likelihood of further cardiac events.

Benefits of Cardivas 3.125 Tablet

The benefits of Cardivas 3.125 Tablet extend beyond its primary uses:

• Blood Pressure Control: By lowering high blood pressure, it helps prevent damage to blood vessels, heart, kidneys, and other organs, which can be caused by hypertension.
• Improvement in Heart Function: For heart failure patients, it enhances heart performance, thereby improving quality of life and reducing hospitalizations due to heart-related issues.
• Reduction of Mortality: Studies have shown that carvedilol can reduce the risk of death in heart failure patients and those who have experienced a heart attack.
• Symptom Relief: Patients often experience significant relief from symptoms such as palpitations, chest pain, and dyspnea (shortness of breath).
• Antioxidant Properties: Carvedilol has been noted for its antioxidant properties, which can contribute to its beneficial effects on the heart and vascular system.

Side Effects of Cardivas 3.125 Tablet

While Cardivas 3.125 Tablet is effective in managing cardiovascular conditions, it can also cause side effects in some patients. Common side effects include:

• Dizziness or Lightheadedness: These are common, particularly when starting the medication or increasing the dose. It is advised to get up slowly from a sitting or lying position to reduce the risk of dizziness.
• Fatigue: Patients might feel unusually tired or weak, which usually diminishes as the body adjusts to the medication.
• Bradycardia (Slow Heart Rate): Carvedilol can lower the heart rate too much in some individuals, leading to symptoms like fatigue, dizziness, or fainting.
• Weight Gain: Some patients may experience weight gain, possibly due to fluid retention.
• Hypotension (Low Blood Pressure): This can cause symptoms such as severe dizziness, fainting, and blurred vision.
• Gastrointestinal Issues: Nausea, diarrhea, and abdominal pain can occur, though these side effects are typically mild.
• Cold Extremities: Patients may notice their hands and feet feeling colder than usual.

Less common but more severe side effects include:

• Allergic Reactions: These can range from mild skin rashes to severe reactions such as difficulty breathing and swelling of the face, lips, tongue, or throat.
• Heart Block: A condition where the electrical signals in the heart are partially or completely blocked, which can be serious.
• Liver Dysfunction: Though rare, carvedilol can cause changes in liver function tests and, in severe cases, liver damage.
• Exacerbation of Asthma or COPD: Due to its non-selective beta-blocking action, carvedilol can worsen symptoms in patients with reactive airway diseases.